ROP
53
-9
C
62
4
NEM
40
3
STT
64
2
V
64
-2
SLB
52
-3
AZO
50
-5
WDC
37
-3
NEE
54
7
IFF
47
-4
URI
60
-6
LUV
45
-2
NOC
41
9
INTC
41
4
BMY
55
-8
HSIC
45
5
GT
56
-3
COST
57
-6
DHI
44
-3
GE
61
-3
ROP
53
-9
C
62
4
NEM
40
3
STT
64
2
V
64
-2
SLB
52
-3
AZO
50
-5
WDC
37
-3
NEE
54
7
IFF
47
-4
URI
60
-6
LUV
45
-2
NOC
41
9
INTC
41
4
BMY
55
-8
HSIC
45
5
GT
56
-3
COST
57
-6
DHI
44
-3
GE
61
-3
Financhill
Back

AVVAA World Health Care Products Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
23

AVVH
AVVAA World Health Care Products

Last Price:
0.0000
Seasonality Move:
99.15%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Sell
23
AVVAA World Health Care Products (AVVH) is a Sell

Is AVVAA World Health Care Products a Buy, Sell or Hold?

  • The current AVVAA World Health Care Products [AVVH] share price is $0.0012. The Score for AVVH is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • AVVH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AVVH Stock Price Chart

What is AVVAA World Health Care Products's stock price today?

  • The AVVAA World Health Care Products share price today is $0.0012
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVVH is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

AVVH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 38.46 Sell
Chaikin Money Flow: -4714 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.0014 - 0.0014) Sell
Bollinger Bands (100): (0.002 - 0.002) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

AVVH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0 Sell
20-day SMA: 0 Sell
50-day SMA: 0 Sell
200-day SMA: 0 Sell
8-day EMA: 0 Sell
20-day EMA: 0 Sell
50-day EMA: 0 Sell
200-day EMA: 0 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

AVVAA World Health Care Products Earnings Growth & AVVH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

AVVAA World Health Care Products Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):